Clinical Nutrition Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Clinical Nutrition Market by product Type (Vitamins and Minerals, Pre/Probiotic, Amino Acids, Glucose, Lipids, Omega Fatty Acids, Others), by Medical Conditions (Metabolic Disorders, Neurological Disorders, Gastrointestinal Disorders, Eating Disorders, Others), by Route of Administration (Oral, Enteral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Clinical Nutrition Market size valued $40.36 billion in 2021 and expected to reach $57.48 billion in 2028 at a CAGR of 8.6% during forecast period 2022-2028. The nutrition of patients in the healthcare industry is referred to as clinical nutrition. Clinical refers to the treatment of outpatients as well as inpatients at clinics and hospitals in this context. Its goal is to help patients maintain a good energy balance while also giving essential nutrients such protein, vitamins, and minerals. Clinical nutrition has several advantages, including its effectiveness in treating type 1 and type 2 diabetes and its ability to help people live better at any age. Outwardly, clinical nutrition items are given to people who are unable to absorb particular nutrients. The market for clinical nutrition is propelling owing to the growing geriatric population who are highly prone to the major health issues related to the metabolic disorders & loss of appetite. Increase in initiatives taken by the governments, Malnutrition, rise in junk foods intake, poverty, lack in awareness are the factors that are fuelling the growth of clinical nutrition market growth. However, strict government regulations, low reimbursement policies, volatility of the market, patient compliance complexities are the factors hampering the market growth.

Key Developments:

In April 2012, Nestle acquired Pfizer Nutrition to increase its position in infant nutrition market globally

In March 2014, Perrigo Company plc and KanPak LLC entered into partnership for manufacturing adult nutritional drinks

In April 2016, Perrigo Company plc, launched Glucerna aseptic nutritional shake for diabetic people

In July 2017, Perrigo Company plc received U.S. FDA approval of AB rated ANDA referencing DermOtic Oil Ear Drops

Clinical Nutrition Market

MARKET SUMMARY
-
8.6% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.6%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Clinical Nutrition Market

  • The report on global clinical nutrition market gives historical, current and future market sizes (US$ Bn) on basis of product type, disease conditions, route of administration, distribution channel and region.
  • clinical nutrition market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Ajinomoto Co. Inc.
  • Perrigo Company Plc
  • Abbott Nutrition Inc.
  • Baxter International Inc.
  • B. Braun Medical Inc.
  • Fresenius Kabi AG.
Clinical Nutrition Market

Drivers and Restrains

The progressive impact of growing population pool of baby boomers is protruded to remain as an intermediate in coming years as expectancy of life is expected to increase due to improvement of standards of health. Rise in the incidence rate of chronic diseases like diabetes, cancer, and HIV/AIDS is driving the global market growth. In paediatric category, increasing demand for the clinical nutrition is emerged as budding opportunity for market of the clinical nutrition. Growing home care use of nutritional products is anticipated to increase demand for the global market.


Asia-Pacific got significant share

Clinical Nutrition Market

Based on geographical region, the global market is segmented as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia- Pacific is dominating the global market of clinical nutritional products. Owing to the high birth rate in countries like India and China are expected to drive the demand for the clinical nutrition products, especially for infant nutrition products. As per the World Bank Group, India has highest birth-rate in APAC region in 2012. In Europe, France and UK have highest birth rate in same year. North America and the Europe are anticipated to dominate global products market during the forecast period owing the rising investments from the manufacturers in R&D for the innovation of novel products with enhancement of nutrition.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Clinical Nutrition Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The clinical nutrition Asaia Pacific is the fastest-growing region for pencil marketmarket is projected to expand at a CAGR of 8.6% during the forecast period

Ajinomoto Co. Inc.,, Perrigo Company Plc, Abbott Nutrition Inc.,, Baxter International Inc., Danon Baby and Medical Nutrition BV,

Asaia Pacific is the fastest-growing region for clinical nutrition market


Report

Table Of Content

1. Executive Summary
2. Global Clinical Nutrition Market Introduction
2.1. Global Clinical Nutrition Market – Taxonomy
2.2. Global Clinical Nutrition Market –Definitions
2.2.1. By Product Type
2.2.2. By Medical Condition
2.2.3. By Route of Administration
2.2.4. By Distribution Channel
2.2.5. By Region
3. Global Clinical Nutrition Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Clinical Nutrition Market Dynamic Factors – Impact Analysis
3.6. Global Clinical Nutrition Market – Competition Landscape
4. Global Clinical Nutrition Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Clinical Nutrition Market, By Product Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Vitamins and Minerals
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) & (Volume, Units)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Pre/Probiotics
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Amino Acids
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Glucose
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Lipids
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Omega Fatty Acids
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Others
5.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
6. Global Clinical Nutrition Market Forecast, By Medical Condition, 2017 – 2021 and Forecast, 2022 – 2028
6.1. Metabolic Disorders
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Neurological Disorders
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Gastrointestinal Disorders
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Eating Disorders
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Clinical Nutrition Market Forecast, By Route of Administration, 2017 – 2021 and Forecast, 2022 – 2028
7.1. Oral
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Enteral
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Parenteral
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Clinical Nutrition Market Forecast, By Distribution Channel, 2017 – 2021 and Forecast, 2022 – 2028
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Others
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Clinical Nutrition Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Clinical Nutrition Market – Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2022 – 2028
10. North America Clinical Nutrition Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Vitamins and Minerals
10.1.2. Pre/Probiotic
10.1.3. Amino Acids
10.1.4. Glucose
10.1.5. Lipids
10.1.6. Omega Fatty Acids
10.1.7. Others
10.2. Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Metabolic Disorders
10.2.2. Neurological Disorders
10.2.3. Gastrointestinal Disorders
10.2.4. Eating Disorders
10.2.5. Others
10.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Oral
10.3.2. Enteral
10.3.3. Parenteral
10.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Others
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Clinical Nutrition Market – Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2022 – 2028
10.7. North America Clinical Nutrition Market Dynamics – Trends
11. Europe Clinical Nutrition Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Vitamins and Minerals
11.1.2. Pre/Probiotic
11.1.3. Amino Acids
11.1.4. Glucose
11.1.5. Lipids
11.1.6. Omega Fatty Acids
11.1.7. Others
11.2. Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Metabolic Disorders
11.2.2. Neurological Disorders
11.2.3. Gastrointestinal Disorders
11.2.4. Eating Disorders
11.2.5. Others
11.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oral
11.3.2. Enteral
11.3.3. Parenteral
11.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Others
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Clinical Nutrition Market – Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2022 – 2028
11.7. Europe Clinical Nutrition Market Dynamics – Trends
12. Asia-Pacific Clinical Nutrition Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Vitamins and Minerals
12.1.2. Pre/Probiotic
12.1.3. Amino Acids
12.1.4. Glucose
12.1.5. Lipids
12.1.6. Omega Fatty Acids
12.1.7. Others
12.2. Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Metabolic Disorders
12.2.2. Neurological Disorders
12.2.3. Gastrointestinal Disorders
12.2.4. Eating Disorders
12.2.5. Others
12.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oral
12.3.2. Enteral
12.3.3. Parenteral
12.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Others
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Clinical Nutrition Market – Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2022 – 2028
12.7. Asia-Pacific Clinical Nutrition Market Dynamics – Trends
13. Latin America Clinical Nutrition Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
13.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Vitamins and Minerals
13.1.2. Pre/Probiotic
13.1.3. Amino Acids
13.1.4. Glucose
13.1.5. Lipids
13.1.6. Omega Fatty Acids
13.1.7. Others
13.2. Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Metabolic Disorders
13.2.2. Neurological Disorders
13.2.3. Gastrointestinal Disorders
13.2.4. Eating Disorders
13.2.5. Others
13.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oral
13.3.2. Enteral
13.3.3. Parenteral
13.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Others
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028  by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Clinical Nutrition Market – Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2022 – 2028
13.7. Latin America Clinical Nutrition Market Dynamics – Trends
14. Middle East and Africa Clinical Nutrition Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
14.1. Product Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Vitamins and Minerals
14.1.2. Pre/Probiotic
14.1.3. Amino Acids
14.1.4. Glucose
14.1.5. Lipids
14.1.6. Omega Fatty Acids
14.1.7. Others
14.2. Medical Condition Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Metabolic Disorders
14.2.2. Neurological Disorders
14.2.3. Gastrointestinal Disorders
14.2.4. Eating Disorders
14.2.5. Others
14.3. Route of Administration Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oral
14.3.2. Enteral
14.3.3. Parenteral
14.4. Distribution Channel Analysis 2017 – 2021 and Forecast 2022 – 2028 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Others
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Clinical Nutrition Market – Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2022 – 2028
14.7. MEA Clinical Nutrition Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Abbott Nutrition
15.2.2. Nestle Health Science
15.2.3. Baxter Healthcare
15.2.4. B. Braun Melsungen AG
15.2.5. DSM
15.2.6. Danone
15.2.7. Fresenius Kabi AG
15.2.8. Hospira (Pfizer) Inc.,
15.2.9. Gentiva Health Services Inc.,
15.2.10. Hero Nutritional Inc.
15.2.11. Ajinomoto Co. Inc.
15.2.12. Perrigo Company Plc
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Ajinomoto Co. Inc.,
  • Perrigo Company Plc
  • Abbott Nutrition Inc.,
  • Baxter International Inc.,
  • Danon Baby and Medical Nutrition BV,
  • B. Braun Medical Inc.,
  • Fresenius Kabi AG,
  • Hospira (Pfizer) Inc.,
  • Gentiva Health Services Inc.,
  • Hero Nutritional Inc., and
  • Nestle SA.

Description

Clinical Nutrition Market size valued $40.36 billion in 2021 and expected to reach $57.48 billion in 2028 at a CAGR of 8.6% during forecast period 2022-2028. The nutrition of patients in the healthcare industry is referred to as clinical nutrition. Clinical refers to the treatment of outpatients as well as inpatients at clinics and hospitals in this context. Its goal is to help patients maintain a good energy balance while also giving essential nutrients such protein, vitamins, and minerals. Clinical nutrition has several advantages, including its effectiveness in treating type 1 and type 2 diabetes and its ability to help people live better at any age. Outwardly, clinical nutrition items are given to people who are unable to absorb particular nutrients. The market for clinical nutrition is propelling owing to the growing geriatric population who are highly prone to the major health issues related to the metabolic disorders & loss of appetite. Increase in initiatives taken by the governments, Malnutrition, rise in junk foods intake, poverty, lack in awareness are the factors that are fuelling the growth of clinical nutrition market growth. However, strict government regulations, low reimbursement policies, volatility of the market, patient compliance complexities are the factors hampering the market growth.

Key Developments:

In April 2012, Nestle acquired Pfizer Nutrition to increase its position in infant nutrition market globally

In March 2014, Perrigo Company plc and KanPak LLC entered into partnership for manufacturing adult nutritional drinks

In April 2016, Perrigo Company plc, launched Glucerna aseptic nutritional shake for diabetic people

In July 2017, Perrigo Company plc received U.S. FDA approval of AB rated ANDA referencing DermOtic Oil Ear Drops

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX